Key opinion leaders emphasize the significant role of immunotherapy for patients being treated for gastroesophageal cancer. James M. Cleary, MD, PhD: Increasingly, hospitals—including mine—have ...
Key opinion leaders navigate unmet needs across the treatment landscape of gastroesophageal cancer. Laura Bobolts, PharmD, BCOP: The unmet need for patients with esophageal and upper–GI ...
AMY, amygdala; DGBIs, disorders of gut-brain interaction; DMV, dorsal motor nucleus of the vagus; ENS, enteric nervous system; Hyp, hypothalamus; NTS, nucleus tractus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results